Compare WST & IEX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | WST | IEX |
|---|---|---|
| Founded | 1923 | 1987 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Fluid Controls |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 18.5B | 15.4B |
| IPO Year | 2004 | 1994 |
| Metric | WST | IEX |
|---|---|---|
| Price | $327.67 | $217.80 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 7 | 8 |
| Target Price | ★ $325.86 | $229.63 |
| AVG Volume (30 Days) | ★ 586.8K | 516.2K |
| Earning Date | 04-23-2026 | 04-29-2026 |
| Dividend Yield | 0.30% | ★ 1.31% |
| EPS Growth | ★ 1.49 | N/A |
| EPS | ★ 1.92 | 1.61 |
| Revenue | $2,886,900,000.00 | ★ $3,457,500,000.00 |
| Revenue This Year | $6.76 | $4.09 |
| Revenue Next Year | $6.22 | $4.36 |
| P/E Ratio | $172.34 | ★ $134.78 |
| Revenue Growth | 1.95 | ★ 5.77 |
| 52 Week Low | $206.80 | $157.25 |
| 52 Week High | $336.82 | $223.94 |
| Indicator | WST | IEX |
|---|---|---|
| Relative Strength Index (RSI) | 61.73 | 58.05 |
| Support Level | $253.53 | $204.03 |
| Resistance Level | N/A | $223.85 |
| Average True Range (ATR) | 8.03 | 4.57 |
| MACD | 0.18 | 0.42 |
| Stochastic Oscillator | 67.72 | 67.34 |
West Pharmaceutical Services is based in Pennsylvania and is a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West sells elastomer-based packaging components (including stoppers, seals, and plungers), nonglass containment solutions, and auto-injectors for injectable drugs, which include large-molecule biologics, peptides such as GLP-1 receptor agonists, and small-molecule drugs. The company reports in two segments: proprietary products (about 80% of total revenue) and contract-manufactured products (about 20% of total revenue). It generates approximately 55% of its revenue from international markets and 45% from the United States.
Idex manufactures pumps, flow meters, valves, and fluidic systems for customers in a variety of end markets, including industrial, fire and safety, life science, and water. The firm's business is organized into three segments: fluid and metering technologies, health and science technologies, and fire and safety and diversified products. The company generated $3.5 billion in revenue in 2025.